KIMS board to review Q2 and half-year financial results

Krishna Institute of Medical Sciences Limited (KIMS) announced that its board of directors will convene on Friday, November 7, 2025. The primary agenda for this meeting is to consider and approve the unaudited standalone and consolidated financial results for the second quarter and the half-year ending September 30, 2025.

In accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has informed both the Bombay Stock Exchange and the National Stock Exchange of this upcoming board meeting.

Furthermore, KIMS has implemented a trading window closure for its designated persons. This restriction on trading in the company's equity shares commenced on Wednesday, October 1, 2025, and will remain in effect until 48 hours after the public disclosure of the financial results. This measure is in line with the company's code of conduct for the prevention of insider trading.